Cancel
Paul McGovern
Senior Vice President, Medical Sciences
@
Venatorx Pharmaceuticals
uwh2w2jd@5k1u7skk.ph4
Sign up to see email
See Linkedin
Known information
- Has more than 20 years of Infectious Diseases experience.
- Has 13 years of experience in anti-infective drug development.
- Serves as the primary scientific and medical advisor to the company’s clinical teams.
- Provides medical input to all aspects of product development and to drug discovery teams.
- Is involved in the planning, implementation, analysis, and interpretation of clinical studies.
- Provides medical expertise necessary to advance development programs to the filing of INDs and NDAs.
- Previously worked as Vice President, Clinical & Medical Affairs at Paratek Pharmaceuticals.
- Worked as Senior Director at Actelion Clinical Research.
- Was Director of Vaccine Research and Clinical Affairs for Infectious Diseases at Wyeth/Pfizer.
- Received a B.S. from the University of Notre Dame.
- Received an M.D. from Northwestern University.
- Completed Internal Medicine and Infectious Diseases training at the University of Pennsylvania.
About Venatorx Pharmaceuticals
Venatorx Pharmaceuticals, founded in June 2010, focuses on developing novel anti-infectives to treat multi-drug-resistant bacterial and hard-to-treat viral infections. Their lead asset, cefepime-taniborbactam, has completed a Phase 3 study for complicated urinary tract infections and is under FDA review.
Report inaccurate information